SPPILawsuitsprnewswire

Spectrum Pharmaceuticals (SPPI) Lead Plaintiff Process Re-Opened, Investors with Losses Urged to Contact Hagens Berman Before September 24, 2025 Deadline

Sentiment:Negative (-40)

Summary

SPPI Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Aug. 12, 2025 /PRNewswire/ -- On August 4, 2025, the court overseeing the pending securities class action styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 12, 2025 by prnewswire